AI-generated summary
The authors evaluated a new intense pulsed light system with dual mode filtering in 24 patients with facial telangiectasias, treated one to four times at one-month intervals. They report that 79.2% of patients had more than a 50% reduction in vessel number, and that only moderate erythema and edema occurred as adverse effects. The study design was a clinical study without a control group, as the abstract does not describe one.
- Participants
- 24
- Who or what was studied
- Patients with facial telangiectasias
- Wavelengths
- 950 nm
- Limits stated in the abstract
- The abstract does not describe a control group, and the sample of 24 patients is small.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 950 nm
How to read a single study: what to check before relying on this kind of research.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.